Home Bistro (HBIS) 10-Q 13 Aug 18 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Aug. 10, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Gratitude Health, Inc.
Entity Central Index Key	1,489,588
Amendment Flag	false
Trading Symbol	GRTD
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,018
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		16,832,065

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
CURRENT ASSETS:
Cash	$ 28,562	$ 20,826
Inventory	71,329
Prepaid expenses and other current assets	15,247
Advance to supplier		11,200
Total Current Assets	115,138	32,026
OTHER ASSETS:
Property and equipment, net	38,013	13,222
Deposit	3,348
Total Other Assets	41,361	13,222
TOTAL ASSETS	156,499	45,248
CURRENT LIABILITIES:
Accounts payable and accrued expenses	76,369	16,046
Convertible notes payable, net of debt discount		100,289
Due to related party		345
Total Current Liabilities	76,369	116,680
Total Liabilities	76,369	116,680
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT):
Common stock $0.001 par value: 300,000,000 shares authorized; 16,832,065 and 49,766,819 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively.	16,832	49,767
Common stock to be issued (2,600,000 and none shares, respectively)	2,600
Additional paid-in capital	736,036	(25,275)
Accumulated deficit	(676,358)	(96,424)
Total Stockholders' Equity (Deficit)	80,130	(71,432)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	156,499	45,248
Series A Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, value	520
Convertible Series B Preferred stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, value	$ 500	$ 500

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	16,832,065	49,766,819
Common stock, shares outstanding	16,832,065	49,766,819
Common stock to be issued	2,600,000
Series A Preferred Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	520,000	520,000
Preferred stock, shares issued	520,000	520,000
Preferred stock, shares outstanding	520,000	520,000
Convertible Series B Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018
Statements of Operations [Abstract]
Net revenues
OPERATING EXPENSES:
Compensation and related cost	79,718	121,018
Professional and consulting expenses	290,919	358,085
General and administrative	49,793	67,313
Total Operating Expenses	420,430	546,416
LOSS FROM OPERATIONS	(420,430)	(546,416)
OTHER EXPENSE:
Interest income	9	9
Interest expense		(33,527)
Other expense	9	(33,518)
LOSS BEFORE PROVISION FOR INCOME TAXES	(420,421)	(579,934)
Provision for income taxes
NET LOSS	$ (420,421)	$ (579,934)
NET LOSS PER COMMON SHARE - Basic and diluted	$ (0.02)	$ (0.02)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and diluted	21,221,144	36,515,264

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Cash Flows (Unaudited)	6 Months Ended
	Jun. 30, 2018USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (579,934)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	4,105
Amortization of debt discount	29,703
Stock-based compensation	234,000
Change in operating assets and liabilities:
Inventory	(71,329)
Prepaid expenses and other current assets	(15,247)
Advance to supplier	11,200
Deposit	(3,348)
Accounts payable and accrued expenses	42,827
NET CASH USED IN OPERATING ACTIVITIES	(348,023)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment	(28,896)
NET CASH USED IN INVESTING ACTIVITIES	(28,896)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds received from issuance of notes payable	120,000
Net proceeds received from issuance of preferred stock	265,000
Repayments on advances from related parties	(345)
NET CASH PROVIDED BY FINANCING ACTIVITIES	384,655
NET INCREASE IN CASH	7,736
CASH, beginning of period	20,826
CASH, end of period	28,562
Cash paid during the period for:
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of preferred stock for conversion of notes payable and accrued interest	281,789
Assumption of liabilities in connection with the reverse merger	$ 22,975

Organization and Operations

Organization and Operations	6 Months Ended
	Jun. 30, 2018
Organization and Operations [Abstract]
Organization and Operations	Note 1 - Organization and Operations Gratitude Health, Inc., (the “Company”) was incorporated in the State of Nevada on December 17, 2009. Effective March 23, 2018, the Company changed its legal name to Gratitude Health, Inc. from Vapir Enterprises Inc. On March 26, 2018, the Company merged with Gratitude Health Inc. (“Gratitude Subsidiary”), a private company incorporated in Florida on September 14, 2017, in a transaction treated as a reverse acquisition and recapitalization effected by a share exchange. The consolidated financial statements are those of Gratitude Subsidiary (the accounting acquirer) prior to the merger and include the activity of the Company (the legal acquirer) from the date of the merger (see Note 7). The Company’s former business was focused on inventing, developing and producing aromatherapy devices and vaporizers before the merger. The Company is now engaged in manufacturing, selling and marketing functional RTD (Ready to Drink) beverages sold under the Company’s trademark. Recent developments- Acquisition On March 26, 2018, Gratitude Subsidiary, a private Florida corporation, entered into a Share Exchange Agreement (the “Exchange Agreement”) with the Company, Hamid Emarlou, the principal shareholder of the Company (“Acquiror Principal Shareholder”), and all of the principal shareholders of Gratitude Subsidiary. Upon closing of the transactions contemplated under the Exchange Agreement (the “Merger”), Gratitude Subsidiary became a wholly-owned subsidiary of the Company. On March 26, 2018, the Company closed the Merger with Gratitude Subsidiary. The Merger has constituted a change in control, the majority of the Board of Directors changed with the consummation of the Merger. The Company issued to the stockholders of Gratitude Subsidiary shares of preferred stock which represented approximately 86% of the combined company on a fully converted basis after the closing of the Exchange Agreement and the Spin off Agreement as described below. On the Closing Date, Acquiror Principal Shareholder entered into a Spin Off Agreement with the Company for the sale of the existing wholly owned Vapir, Inc. subsidiary of the Company in exchange for Acquiror Principal Shareholder’s 36,309,768 shares of Common Stock. The Spin Off Agreement closed on April 14, 2018. The Company recognized the disposition of the Vapir business on the date of merger.

Significant and Critical Accoun

Significant and Critical Accounting Policies and Practices	6 Months Ended
	Jun. 30, 2018
Significant and Critical Accounting Policies and Practices [Abstract]
Significant and Critical Accounting Policies and Practices	Note 2 - Significant and Critical Accounting Policies and Practices Basis of Presentation The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information, which includes condensed consolidated financial statements and present the consolidated financial statements of the Company and its wholly-owned subsidiaries as of June 30, 2018. All intercompany transactions and balances have been eliminated. Accordingly, the condensed consolidated financial statements do not include all the information and notes necessary for a comprehensive presentation of financial position and results of operations and should be read in conjunction with the audited financial statements of Gratitude Subsidiary for the period from September 14, 2017 (inception) to December 31, 2017 and included in the form 8-K/A filed with the SEC on May 15, 2018. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. Significant intercompany accounts and transactions have been eliminated in consolidation. The results for the interim period are not necessarily indicative of the results to be expected for the year ending December 31, 2018. Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In preparing the unaudited condensed consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated balance sheet, and revenues and expenses for the period then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to valuation of deferred tax assets, useful life of property and equipment, inventory reserves, and valuation of debt discounts. Cash equivalents The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2018, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Fair value measurements and fair value of financial instruments The estimated fair value of certain financial instruments, including cash, advance to supplier, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. Inventory The Company values inventory, consisting of finished goods, at the lower of cost or market. Cost is determined on the first-in and first-out (“FIFO”) method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures. The Company did not record any allowance for slow moving inventory as of June 30, 2018. Advances to suppliers Advances to a supplier represents the cash paid in advance for the purchase of inventory. The advances to a supplier are interest free and unsecured. As of June 30, 2018 and December 31, 2017, advances to the Company’s major supplier amounted to $0 and $11,200, respectively. Upon shipment of the purchase inventory, the Company reclassifies or records such advances to the supplier into inventory. Property and Equipment Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets of 3 years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired, or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the consolidated statement of operations. Revenue Recognition The Company will recognize revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers, which requires revenue to be recognized in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company will further analyze its revenue recognition policy when it enters into revenue producing customer contracts. Advertising Costs The Company applies ASC 720 “Other Expenses” to account for advertising related costs. Pursuant to ASC 720-35-25-1, the Company expenses the advertising costs when the first time the advertising takes place. Advertising costs were $2,085 for the six months ended June 30, 2018. Income Taxes The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed. Basic and diluted net loss per share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The following were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss. In periods where the Company has a net loss, all dilutive securities are excluded. For the Stock Options 1,940,000 Convertible Preferred Stock 102,000,000 Common stock to be issued 2,600,000 Total 106,540,000 Recent accounting pronouncements In August 2015, the FASB issued ASU 2015-14 Revenue from Contracts with Customers. The ASU defers the effective date of previously issued ASU 2014-09 (the new revenue recognition standard) by one year for both public and private companies. The ASU requires public entities to apply the new revenue recognition guidance for annual reporting periods beginning after December 15, 2017, and interim reporting periods within annual reporting periods beginning after December 15, 2017. Both public and nonpublic entities will be permitted to apply the new revenue recognition standard as of the original effective date for public entities (annual periods beginning after December 15, 2016). The Company adopted this standard for their fiscal year beginning January 1, 2018. The Company does not expect this ASU to have a material impact on its financial statements. In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods and is applied retrospectively. Early adoption is permitted. The Company does not believe the guidance will have a material impact on its financial statements. In January 2017, the Financial Accounting Standard Board’s (“FASB”) issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates Step 2 from the goodwill impairment test. When an indication of impairment was identified after performing the first step of the goodwill impairment test, Step 2 required that an entity determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) using the same procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Under the amendments in ASU No. 2017-04, an entity would perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying value. An entity would recognize an impairment charge for the amount by which the carrying value exceeds the reporting unit’s fair value. In addition, an entity must consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. A public business entity that is a SEC filer should adopt the amendments in ASU No. 2017-04 for its annual, or any interim, good will impairment tests in fiscal years beginning after December 15, 2019. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In July 2017, the FASB issued ASU 2017-11 “Earnings Per Share (Topic 260)”. The amendments in the update change the classification of certain equity-linked financial instruments (or embedded features) with down round features. The amendments also clarify existing disclosure requirements for equity-classified instruments. For freestanding equity-classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260, Earnings Per Share, to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features would be subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company adopted this pronouncement as of fiscal 2017. In August 2017, the FASB issued ASU 2017-12 “Derivatives and Hedging (Topic 815) Targeted Improvements to Accounting for Hedging Activities”. ASU 2017-12 eliminates the requirement to separately measure and report hedge ineffectiveness and generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. The guidance also eases certain documentation and assessment requirements and modifies the accounting for components excluded from the assessment of hedge effectiveness. The guidance is effective for the Company beginning after December 15, 2018, although early adoption is permitted. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In June 2018, the FASB issued ASU No. 2018-07 “Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. The guidance is effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company is assessing ASU 2018-07 and does not expect it to have a material impact on its accounting and disclosures. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2018
Going Concern [Abstract]
Going Concern	Note 3 - Going Concern The Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the condensed consolidated financial statements, the Company has an accumulated deficit of approximately $676,000 at June 30, 2018, and incurred a net loss of approximately $580,000 and net cash used in operating activities of approximately $348,000 for the six months ended June 30, 2018. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the date of this report. The ability of the Company to continue as a going concern is dependent on the Company’s ability to implement its business plan, raise capital, and generate revenues. Currently, management is seeking capital to implement its business plan. Management believes that the actions presently being taken provide the opportunity for the Company to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2018
Property and Equipment [Abstract]
Property and Equipment	Note 4 - Property and Equipment Property and equipment, stated at cost, less accumulated depreciation consisted of the following: Estimated life As of As of Molding Tool equipment 3 years $ 23,140 $ 14,000 Packing equipment 3 years 19,756 - Less: Accumulated depreciation (4,883 ) (778 ) $ 38,013 $ 13,222 Depreciation expense amounted to $4,105 for the six months ended June 30, 2018.

Convertible Notes Payable

Convertible Notes Payable	6 Months Ended
	Jun. 30, 2018
Convertible Notes Payable [Abstract]
Convertible Notes Payable	Note 5 – Convertible Notes Payable Convertible notes payable consisted of the following: June 30, December 31, Convertible notes payable $ - $ 120,000 Debt discount - (19,711 ) Total convertible notes payable $ - $ 100,289 Between October 2017 to December 2017, the Company issued 12% convertible notes payable and 5 year warrants to acquire an aggregate of 12,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The notes were due one year from the date of issuance. The annual interest rate for the notes were 12%. The notes were convertible any time after the issuance date of the note at $0.01 per share. The Company accounted for the warrants by using the relative fair value method. The debt discount consisted of relative fair value of the warrants of $9,992 using a Black-Scholes model with the following assumptions: dividend yield of zero, years to maturity of 5.00, a risk free rate of 2.00%, and expected volatility of 200% using volatilities of similar companies. The Company also paid financing costs of $15,000 in connection with these notes which was initially recorded as debt discount and was amortized over the term of these notes. Between January 2018 to March 2018, the Company through the Company’s wholly owned subsidiary, Gratitude Subsidiary, entered into promissory note agreements, providing for the issuance of notes in the principal amount of $120,000 to an unrelated party pursuant to a Securities Purchase Agreement. The notes were due one year from the date of issuance. The annual interest rate for the notes were 12%. The notes were convertible any time after the issuance date of the note at $0.01 per share. The Company granted the note holder an aggregate of 12,000,000 warrants in connection with the issuance of these notes. The warrants had a term of 5 years from the date of grant and was exercisable at an exercise price of $0.02. The Company accounted for the warrants by using the relative fair value method. The debt discount consisted of relative fair value of the warrants of $9,992 using a Black-Scholes model with the following assumptions: dividend yield of zero, years to maturity of 5.00, a risk free rate of 2.00%, and expected volatility of 200% using volatilities of similar companies. In connection with the merger, the Company entered into a Surrender and Exchange Agreement with these note holders whereby the note holders agreed to surrender the 12% convertible notes including accrued interest for a total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holders. Such surrender of notes and warrants was done in connection with the Exchange Agreement which closed on March 26, 2018. Accordingly, the Company fully amortized the debt discount of $29,703 for the six months ended June 30, 2018 and such 24,000,000 warrants granted by Gratitude Subsidiary were cancelled as of June 30, 2018. As of June 30, 2018, principal amount of the notes and accrued interest outstanding was $0.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 - Related Party Transactions The Company’s chief executive officer, Mr. Roy Warren, from time to time, provided advances to the Company for working capital purposes. At June 30, 2018, and December 31, 2017, the Company had a payable to the officer of $0 and $345. These advances were short-term in nature and non-interest bearing. In connection with the Exchange Agreement (see Note 7), the Company issued 500,000 shares of Series A Preferred Stock to the founders who are the CEO and COO of the Company.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	6 Months Ended
	Jun. 30, 2018
Stockholders' Equity (Deficit) [Abstract]
Stockholders' Equity (Deficit)	Note 7 - Stockholders’ Equity (Deficit) Shares Authorized The authorized capital of the Company consists of 300,000,000 shares of common stock, par value $0.001 per share and 20,000,000 shares of preferred stock, par value $0.001 per share. On March 19, 2018, the Board of Directors of the Company approved and amended its Articles of Incorporation to include two series of preferred stock authorized, Series A and Series B Preferred Stock. Preferred stock On March 19, 2018, the Company designated 520,000 shares of Series A Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) Each share of Series A Preferred Stock is convertible into shares of the Company’s common stock with a stated value of $10 per share and conversion price of $0.10 per share of common stock, subject to adjustment in the event of stock split, stock dividends, and recapitalization or otherwise. The holders of the Series A Preferred Stock shall not possess any voting rights. The Series A Preferred Stock does not contain any redemption provision. The Series C Preferred Stock are entitled to receive in cash out of assets of the Company before any amounts shall be paid to the holders of any of shares of Junior stock, an amount equal to the stated value plus any accrued and unpaid dividends thereon and any other fees due and owing. On March 19, 2018, the Company designated 500,000 shares of Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) Each share of Series B Preferred Stock is convertible into shares of the Company’s common stock with a stated value of $10 per share and conversion price of $0.10 per share of common stock, subject to adjustment in the event of stock split, stock dividends, and recapitalization or otherwise. The Series B Preferred Stock votes with the common stock on a fully as converted basis. The Series B Preferred Stock does not contain any redemption provision. The Series C Preferred Stock are entitled to receive in cash out of assets of the Company before any amounts shall be paid to the holders of any of shares of Junior stock, an amount equal to the stated value plus any accrued and unpaid dividends thereon and any other fees due and owing. Share Exchange Agreement On March 26, 2018, Gratitude Health, Inc. f/ka Vapir Enterprises, Inc., a corporation organized under the laws of Nevada (the “Acquiror” or the “Company”), Hamid Emarlou, the principal shareholder of the Acquiror (the “Acquiror Principal Shareholder”), Gratitude Health, Inc., a corporation organized under the laws of Florida (the “Acquiree” or “Gratitude Subsidiary”), and each of the Persons who are shareholders of the Acquiree (collectively, the “Acquiree Shareholders,” and individually an “Acquiree Shareholder”) entered into a Share Exchange Agreement pursuant to which the Acquiree Shareholders (who are the holders of all the issued and outstanding shares of common stock of the Acquiree (the “Acquiree Interests”)) have agreed to transfer to the Acquiror, and the Acquiror has agreed to acquire from the Acquiree Shareholders, all of the Acquiree Interests, in exchange for the issuance of 520,000 shares of Series A Preferred Stock and 500,000 shares of Series B Preferred Stock, to the Acquiree Shareholders (the “Acquiror Shares”), which Acquiror Shares shall, upon conversion into 102,000,000 shares of common stock of the Acquiror, constitute approximately 85.84% on a fully diluted basis of the issued and outstanding shares of Acquiror common stock immediately after the closing of the transactions on the terms and conditions as set forth in the Exchange Agreement and the closing of the Spin Off Agreement as described below. Effective March 26, 2018, the Company acquired all the issued and outstanding shares of the Acquiree pursuant to the Exchange Agreement and the Acquiree became the Company’s wholly-owned subsidiary. As a result of the Exchange Agreement, for financial statement reporting purposes, the business combination between the Company and Acquiree has been treated as a reverse acquisition and recapitalization with the Acquiree deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (“ASC”) Section 805-10-55. At the time of the Share Exchange Agreement, both the Company and Acquiror have their own separate operating segments. Accordingly, the assets and liabilities and the historical operations that are reflected in the consolidated financial statements after the Exchange Agreement are those of the Acquiree and are recorded at the historical cost basis of the Acquiree. The acquisition process utilizes the capital structure of the Company and the assets and liabilities of the Acquiree which are recorded at historical cost. The results of operations of the Company are consolidated with results of operations of the Acquiree starting on the date of the Exchange Agreement. The Merger has constituted a change of control or change in control, the majority of the Board of Directors changed with the consummation of the Merger. The Company issued to Acquiree shares of preferred stock which represented approximately 86% of the combined company on a fully converted basis after the closing of the Exchange Agreement and the Spin off Agreement as described below. On the Closing Date, Acquiror Principal Shareholder entered into a Spin Off Agreement with Acquiror for the sale of the existing wholly owned Vapir, Inc. subsidiary of the Company in exchange for Acquiror Principal Shareholder’s 36,309,768 shares of Common Stock. The Spin Off Agreement closed on April 14, 2018. As such, the Company recognized the disposition of the Vapir business on the date of merger. In March 2018, in connection with the Exchange Agreement, the Company issued 20,000 Series A Preferred stock for purchase price of $2,000. In March 2018, in connection with the Exchange Agreement, the Company issued 490,000 Series A Preferred Stock for a purchase price of (i) $3,000 cash, (ii) the satisfaction of the convertible notes including any accrued interest for a total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holder pursuant to the Surrender and Exchange Agreement, (see Note 5) (iii) $260,000 additional funding in cash after the closing of an Exchange Agreement which is recorded as subscription receivable and (iv) the surrender and cancellation of a certain note and warrants owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $70,000 and accrued interest of $59,807. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018. The subscription receivable of $260,000 was collected in April 2018. In March 2018, in connection with the Exchange Agreement, the Company issued 10,000 Series A Preferred Stock in exchanged for the surrender and cancellation of a certain note for a principal amount of $102,500 and accrued interest of $16,350 and warrants issued and owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $70,000 and accrued interest of $59,807. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018. In connection with the Exchange Agreement, the Company issued 500,000 shares of Series A Preferred Stock to the founders who are the CEO and COO of the Company. Common Stock In connection with the Exchange Agreement, the Company is deemed to have issued 53,141,833 shares of common stock which represents the outstanding common shares of the Company prior to the closing of the Merger. In connection with the Spin Off Agreement which closed on April 14, 2018, the Company cancelled the 36,309,768 shares. In April 2018, the Company granted an aggregate of 2,600,000 shares of the Company’s common stock to various consultants and service providers for services rendered. The Company valued these common shares at the fair value of $234,000 or $0.09 per common share based on the closing trading price on the date of grant. The Company recorded stock-based compensation of $234,000 during the six months ended June 30, 2018. In connection with these transactions, there were 2,600,000 shares of common stock to be issued as of June 30, 2018. Common Stock Warrants A summary of the Company’s outstanding stock warrants as of June 30, 2018 and changes during the period presented below: Number of Weighted Average Weighted Balance at December 31, 2017 12,000,000 $ 0.02 4.85 Granted 12,000,000 0.02 5.00 Cancelled (24,000,000 ) 0.10 4.70 Balance at June 30, 2018 - $ - - Warrants exercisable at June 30, 2018 - $ - - Weighted average fair value of warrants granted during the six months ended June 30, 2018 $ 0.001 In March 2018 in connection with the merger, the Company entered into Surrender and Exchange Agreements with note holders whereby the note holders agreed to surrender the 12% convertible notes including accrued interest for a total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holders. Such surrender of notes and warrants was done in connection with the Exchange Agreement which closed on March 26, 2018 (see Note 5). Common Stock Options Stock option activity for the six months ended June 30, 2018 is summarized as follows: Number of Options Weighted Average Exercise Weighted Average Remaining Contractual Life Aggregate Intrinsic Balance at December 31, 2017 - - - - Recapitalization on March 26, 2018 1,940,000 0.10 2.80 - Balance at June 30, 2018 1,940,000 0.10 2.79 - Options exercisable at June 30, 2018 1,940,000 $ 0.10 2.54 $ - As of June 30, 2018, all outstanding options are fully vested and there were $0 unrecognized compensation expense in connection with unvested stock options.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2018
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 8 - Commitments and Contingencies License Agreement In January 2018, the Company entered into a Standard Exclusive License Agreement (the “License Agreement”) whereby the licensor agreed to grant exclusive license to the Company for licensed patent owned or controlled by licensor. The licensed patent is related to tea polyphenols esters and analogs for cancer prevention and treatment. The term of this license shall begin on the effective date of this License Agreement and continue until the later of the date that no licensed patent remains a pending application or an enforceable patent, or the date on which Company’s obligation to pay royalties expires pursuant to the License Agreement. If the Company has not pursued a market or territory respecting the licensed patents within one year of the date of execution of this License Agreement and Licensor has received notice that a third party wishes to negotiate a license for such market or territory, Licensor may terminate the license granted in with respect to such market or territory upon sixty (60) days written notice to Licensee. The Company agreed to pay license issue fee of $5,000 within 30 days of the effective date which was paid in March 2018. Additionally, the Company agreed to pay certain royalty payments as follows: (i) three percent (3%) for Net Sales of Licensed Products, and Licensed Processes (all as defined in the License Agreement), for each product or process, on a country-by-country basis, for cumulative Net Sales up to one million dollars ($1,000,000); and (ii) four percent (4%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, for cumulative Net Sales from one million dollars ($1,000,000) to five million dollars ($5,000,000); and (iii) five percent (5%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, Net Sales over five million dollars ($5,000,000). Furthermore, the Company agrees to pay Licensor minimum royalty payments, as follows: Payment Year $ 20,000 2018 $ 50,000 2019 $ 100,000 2020 and every year thereafter on the same date, for the life of this License Agreement. The minimum royalty shall be paid in advance on a quarterly basis for each year in which this License Agreement is in effect. The first minimum royalty payment shall be due on March 31 st In April 2018, the Company entered into a lease agreement for its corporate facility in Palm Beach Gardens, Florida. The lease is for a period of 36 months commencing in July 2018 and expiring in July 2021. Pursuant to the lease agreement, the lease requires the Company to pay a monthly base rent of $2,154 plus a pro rata share of operating expenses beginning July 2018. The base rent is subject to annual increases beginning the 2nd and 3rd lease year as defined in the lease agreement. Future minimum rental payments required under operating leases are as follows: 2018 $ 12,924 2019 26,238 2020 27,028 2021 13,710 $ 79,900

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	Note 9 - Subsequent events On July 26, 2018, the Company received an advance deposit of $75,000 towards a pending subscription agreement for the sale of the Company’s preferred stock. Such advance deposit shall be applied towards the subscription agreement upon execution.

Significant and Critical Acco15

Significant and Critical Accounting Policies and Practices (Policies)	6 Months Ended
	Jun. 30, 2018
Significant and Critical Accounting Policies and Practices [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information, which includes condensed consolidated financial statements and present the consolidated financial statements of the Company and its wholly-owned subsidiaries as of June 30, 2018. All intercompany transactions and balances have been eliminated. Accordingly, the condensed consolidated financial statements do not include all the information and notes necessary for a comprehensive presentation of financial position and results of operations and should be read in conjunction with the audited financial statements of Gratitude Subsidiary for the period from September 14, 2017 (inception) to December 31, 2017 and included in the form 8-K/A filed with the SEC on May 15, 2018. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. Significant intercompany accounts and transactions have been eliminated in consolidation. The results for the interim period are not necessarily indicative of the results to be expected for the year ending December 31, 2018.
Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions	Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In preparing the unaudited condensed consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated balance sheet, and revenues and expenses for the period then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to valuation of deferred tax assets, useful life of property and equipment, inventory reserves, and valuation of debt discounts.
Cash equivalents	Cash equivalents The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2018, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.
Fair value measurements and fair value of financial instruments	Fair value measurements and fair value of financial instruments The estimated fair value of certain financial instruments, including cash, advance to supplier, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
Inventory	Inventory The Company values inventory, consisting of finished goods, at the lower of cost or market. Cost is determined on the first-in and first-out (“FIFO”) method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures. The Company did not record any allowance for slow moving inventory as of June 30, 2018.
Advances to suppliers	Advances to suppliers Advances to a supplier represents the cash paid in advance for the purchase of inventory. The advances to a supplier are interest free and unsecured. As of June 30, 2018 and December 31, 2017, advances to the Company’s major supplier amounted to $0 and $11,200, respectively. Upon shipment of the purchase inventory, the Company reclassifies or records such advances to the supplier into inventory.
Property and Equipment	Property and Equipment Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets of 3 years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired, or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the consolidated statement of operations.
Revenue Recognition	Revenue Recognition The Company will recognize revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers, which requires revenue to be recognized in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company will further analyze its revenue recognition policy when it enters into revenue producing customer contracts.
Advertising Costs	Advertising Costs The Company applies ASC 720 “Other Expenses” to account for advertising related costs. Pursuant to ASC 720-35-25-1, the Company expenses the advertising costs when the first time the advertising takes place. Advertising costs were $2,085 for the six months ended June 30, 2018.
Income Taxes	Income Taxes The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.
Basic and diluted net loss per share	Basic and diluted net loss per share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The following were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss. In periods where the Company has a net loss, all dilutive securities are excluded. For the Stock Options 1,940,000 Convertible Preferred Stock 102,000,000 Common stock to be issued 2,600,000 Total 106,540,000
Recent accounting pronouncements	Recent accounting pronouncements In August 2015, the FASB issued ASU 2015-14 Revenue from Contracts with Customers. The ASU defers the effective date of previously issued ASU 2014-09 (the new revenue recognition standard) by one year for both public and private companies. The ASU requires public entities to apply the new revenue recognition guidance for annual reporting periods beginning after December 15, 2017, and interim reporting periods within annual reporting periods beginning after December 15, 2017. Both public and nonpublic entities will be permitted to apply the new revenue recognition standard as of the original effective date for public entities (annual periods beginning after December 15, 2016). The Company adopted this standard for their fiscal year beginning January 1, 2018. The Company does not expect this ASU to have a material impact on its financial statements. In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods and is applied retrospectively. Early adoption is permitted. The Company does not believe the guidance will have a material impact on its financial statements. In January 2017, the Financial Accounting Standard Board’s (“FASB”) issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates Step 2 from the goodwill impairment test. When an indication of impairment was identified after performing the first step of the goodwill impairment test, Step 2 required that an entity determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) using the same procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Under the amendments in ASU No. 2017-04, an entity would perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying value. An entity would recognize an impairment charge for the amount by which the carrying value exceeds the reporting unit’s fair value. In addition, an entity must consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. A public business entity that is a SEC filer should adopt the amendments in ASU No. 2017-04 for its annual, or any interim, good will impairment tests in fiscal years beginning after December 15, 2019. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In July 2017, the FASB issued ASU 2017-11 “Earnings Per Share (Topic 260)”. The amendments in the update change the classification of certain equity-linked financial instruments (or embedded features) with down round features. The amendments also clarify existing disclosure requirements for equity-classified instruments. For freestanding equity-classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260, Earnings Per Share, to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features would be subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company adopted this pronouncement as of fiscal 2017. In August 2017, the FASB issued ASU 2017-12 “Derivatives and Hedging (Topic 815) Targeted Improvements to Accounting for Hedging Activities”. ASU 2017-12 eliminates the requirement to separately measure and report hedge ineffectiveness and generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. The guidance also eases certain documentation and assessment requirements and modifies the accounting for components excluded from the assessment of hedge effectiveness. The guidance is effective for the Company beginning after December 15, 2018, although early adoption is permitted. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In June 2018, the FASB issued ASU No. 2018-07 “Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. The guidance is effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company is assessing ASU 2018-07 and does not expect it to have a material impact on its accounting and disclosures. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Significant and Critical Acco16

Significant and Critical Accounting Policies and Practices (Tables)	6 Months Ended
	Jun. 30, 2018
Significant and Critical Accounting Policies and Practices [Abstract]
Schedule of securities excluded from the computation of diluted shares outstanding	For the Stock Options 1,940,000 Convertible Preferred Stock 102,000,000 Common stock to be issued 2,600,000 Total 106,540,000

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2018
Property and Equipment [Abstract]
Schedule of property and equipment	Estimated life As of As of Molding Tool equipment 3 years $ 23,140 $ 14,000 Packing equipment 3 years 19,756 - Less: Accumulated depreciation (4,883 ) (778 ) $ 38,013 $ 13,222

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2018
Convertible Notes Payable [Abstract]
Schedule of convertible notes payable	June 30, December 31, Convertible notes payable $ - $ 120,000 Debt discount - (19,711 ) Total convertible notes payable $ - $ 100,289

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	6 Months Ended
	Jun. 30, 2018
Common Stock Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option and warrant activities	Number of Weighted Average Weighted Balance at December 31, 2017 12,000,000 $ 0.02 4.85 Granted 12,000,000 0.02 5.00 Cancelled (24,000,000 ) 0.10 4.70 Balance at June 30, 2018 - $ - - Warrants exercisable at June 30, 2018 - $ - - Weighted average fair value of warrants granted during the six months ended June 30, 2018 $ 0.001
Common Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option and warrant activities	Number of Options Weighted Average Exercise Weighted Average Remaining Contractual Life Aggregate Intrinsic Balance at December 31, 2017 - - - - Recapitalization on March 26, 2018 1,940,000 0.10 2.80 - Balance at June 30, 2018 1,940,000 0.10 2.79 - Options exercisable at June 30, 2018 1,940,000 $ 0.10 2.54 $ -

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2018
Commitments and Contingencies [Abstract]
Schedule of licensor minimum royalty payments	Payment Year $ 20,000 2018 $ 50,000 2019 $ 100,000 2020 and every year thereafter on the same date, for the life of this License Agreement.
Schedule of future minimum rental payments	2018 $ 12,924 2019 26,238 2020 27,028 2021 13,710 $ 79,900

Subsequent Events (Details)

Subsequent Events (Details)	1 Months Ended
	Jul. 26, 2018USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Advance deposit	$ 75,000

Organization and Operations (De

Organization and Operations (Details) - shares	Apr. 14, 2018	Mar. 26, 2018
Organization and Operations (Textual)
Subsidiary shares of preferred stock percentage		86.00%
Spin Off Agreement [Member]
Organization and Operations (Textual)
Common stock issued in exchange	36,309,768

Significant and Critical Acco23

Significant and Critical Accounting Policies and Practices (Details)	6 Months Ended
	Jun. 30, 2018shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	106,540,000
Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	1,940,000
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	102,000,000
Common stock to be issued [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	2,600,000

Significant and Critical Acco24

Significant and Critical Accounting Policies and Practices (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Significant and Critical Accounting Policies and Practices (Textual)
Amount insured by the FDIC	$ 250,000
Advance to supplier		$ 11,200
Estimated useful lives of the assets	3 years
Advertising costs	$ 2,085

Going Concern (Details)

Going Concern (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Dec. 31, 2017
Going Concern (Textual)
Accumulated deficit	$ (676,358)	$ (676,358)	$ (96,424)
Net loss	$ (420,421)	(579,934)
Net cash used in operating activities		$ (348,023)

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	6 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Summary of property and equipment
Less: Accumulated depreciation	$ (4,883)	$ (778)
Property and equipment, net	$ 38,013	13,222
Molding Tool equipment [Member]
Summary of property and equipment
Estimated life	3 years
Property and equipment, gross	$ 23,140	14,000
Packing equipment [Member]
Summary of property and equipment
Estimated life	3 years
Property and equipment, gross	$ 19,756

Property and Equipment (Detai27

Property and Equipment (Details Textual)	6 Months Ended
	Jun. 30, 2018USD ($)
Property and Equipment (Textual)
Depreciation expense	$ 4,105

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Convertible Notes Payable [Abstract]
Convertible notes payable		$ 120,000
Debt discount		(19,711)
Total convertible notes payable		$ 100,289

Convertible Notes Payable (De29

Convertible Notes Payable (Details Textual) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2017	Jun. 30, 2018
Surrender and Exchange Agreement [Member]
Convertible Notes Payable (Textual)
Principal amount		$ 240,000
Amortization of debt discount		$ 29,703
Number of warrants cancelled		24,000,000
Accrued interest		$ 0
12% Convertible Notes Payable [Member]
Convertible Notes Payable (Textual)
Annual interest rate	12.00%
Notes conversion price	$ 0.01
Financing costs	$ 15,000
12% Convertible Notes Payable [Member] | Common Stock Warrants [Member]
Convertible Notes Payable (Textual)
Warrants term	5 years
Warrants exercise price	$ 0.02
Fair value of the warrants	$ 9,992
Dividend yield	0.00%
Years to maturity	5 years
Risk free rate	2.00%
Expected volatility	200.00%
12% Convertible Notes Payable [Member] | Common Stock [Member]
Convertible Notes Payable (Textual)
Warrants issued to acquire number of shares	12,000,000
Promissory note [Member]
Convertible Notes Payable (Textual)
Annual interest rate		12.00%
Notes conversion price		$ 0.01
Principal amount		$ 120,000
Promissory note [Member] | Common Stock Warrants [Member]
Convertible Notes Payable (Textual)
Warrants term		5 years
Warrants issued to acquire number of shares		12,000,000
Warrants exercise price		$ 0.02
Fair value of the warrants		$ 9,992
Dividend yield		0.00%
Years to maturity		5 years
Risk free rate		2.00%
Expected volatility		200.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	1 Months Ended	6 Months Ended
	Mar. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Related Party Transactions (Textual)
Payable to the officer			$ 345
Series A Preferred Stock [Member]
Related Party Transactions (Textual)
Founder shares issued	10,000
CEO [Member] | Series A Preferred Stock [Member]
Related Party Transactions (Textual)
Founder shares issued		500,000

Stockholders' Equity (Deficit31

Stockholders' Equity (Deficit) (Details) - Common Stock Warrants [Member]	6 Months Ended
	Jun. 30, 2018$ / sharesshares
Summary of stock warrant activities
Number of Warrants/Option, Beginning Balance | shares	12,000,000
Number of Warrants/Option, Granted | shares	12,000,000
Number of Warrants/Option, Cancelled | shares	(24,000,000)
Number of Warrants/Option, Ending Balance | shares
Number of Warrants/Options, exercisable | shares
Weighted Average Exercise Price, Beginning Balance	$ 0.02
Weighted Average Exercise price, Granted	0.02
Weighted Average Exercise Price, Cancelled	0.10
Weighted Average Exercise Price, Ending Balance
Warrants/Options exercisable, Weighted Average Exercise Price
Weighted Average Remaining Contractual Life (Years)	4 years 10 months 6 days
Weighted Average Remaining Contractual Life (Years), Granted	5 years
Weighted Average Remaining Contractual Life (Years), Cancelled	4 years 8 months 12 days
Weighted average fair value of warrants granted	$ 0.001

Stockholders' Equity (Deficit32

Stockholders' Equity (Deficit) (Details 1) - Common Stock Options [Member]	6 Months Ended
	Jun. 30, 2018USD ($)$ / sharesshares
Summary of option activities
Number of Warrants/Option, Beginning Balance | shares
Number of Options, Recapitalization on March 26, 2018 | shares	1,940,000
Number of Warrants/Option, Ending Balance | shares	1,940,000
Number of Warrants/Options, exercisable | shares	1,940,000
Weighted Average Exercise Price, Beginning Balance | $ / shares
Weighted Average Exercise Price, Recapitalization on March 26, 2018 | $ / shares	0.10
Weighted Average Exercise Price, Ending Balance | $ / shares	0.10
Warrants/Options exercisable, Weighted Average Exercise Price | $ / shares	$ 0.10
Weighted Average Remaining Contractual Life (Years)	2 years 9 months 14 days
Weighted Average Remaining Contractual Life (Years), Recapitalization on March 26, 2018	2 years 9 months 18 days
Weighted Average Remaining Contractual Life (Years), Warrants/Options exercisable	2 years 6 months 14 days
Aggregate Intrinsic Value, Option outstanding, Beginning balance | $
Aggregate Intrinsic Value, Recapitalization | $
Aggregate Intrinsic Value, Option outstanding, Ending balance | $
Aggregate Intrinsic Value, Option exercisable | $

Stockholders' Equity (Deficit33

Stockholders' Equity (Deficit) (Details Textual) - USD ($)	Apr. 14, 2018	Apr. 30, 2018	Mar. 31, 2018	Mar. 26, 2018	Mar. 19, 2018	Jun. 30, 2018	Dec. 31, 2017
Stockholders' Equity (Deficit) (Textual)
Common stock, shares authorized						300,000,000	300,000,000
Common stock, par value						$ 0.001	$ 0.001
Preferred stock, shares authorized						20,000,000	20,000,000
Preferred stock, par value						$ 0.001	$ 0.001
Unrecognized compensation expense						$ 0
Stock based compensation						$ 234,000
Share Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares issued			490,000
Preferred stock, description				The Company issued to Acquiree shares of preferred stock which represented approximately 86% of the combined company on a fully converted basis after the closing of the Exchange Agreement and the Spin off Agreement
Conversion of common stock, shares issued				102,000,000
Percentage of diluted basis				85.84%
Series A Preferred Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized						520,000	520,000
Preferred stock, par value					$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares issued						520,000	520,000
Preferred stock, description			In exchanged for the surrender and cancellation of a certain note for a principal amount of $102,500 and accrued interest of $16,350 and warrants issued and owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $70,000 and accrued interest of $59,807. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018.
Number of shares issued on exchange					520,000
Number of stock issued			10,000
Common stock conversion price					$ 0.10
Series A Preferred Stock [Member] | CEO [Member]
Stockholders' Equity (Deficit) (Textual)
Number of stock issued						500,000
Series A Preferred Stock [Member] | Share Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares issued						20,000
Preferred stock, description			A purchase price of (i) $3,000 cash, (ii) the satisfaction of the convertible notes including any accrued interest for a total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holder pursuant to the Surrender and Exchange Agreement, (see Note 5) (iii) $260,000 additional funding in cash after the closing of an Exchange Agreement which is recorded as subscription receivable and (iv) the surrender and cancellation of a certain note and warrants owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $70,000 and accrued interest of $59,807. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018. The subscription receivable of $260,000 was collected in April 2018.
Common stock price per share			$ 2,000
Number of shares issued on exchange				520,000
Number of stock issued			20,000
Share Price			$ 2,000
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized						500,000	500,000
Preferred stock, par value					$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares issued						500,000	500,000
Number of shares issued on exchange					500,000
Common stock conversion price					$ 0.10
Series B Preferred Stock [Member] | Share Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Number of shares issued on exchange				500,000
Common Stock [Member] | Share Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Number of stock issued			53,141,833
12% convertible notes [Member] | Share Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Total principal amount			$ 240,000
Common Stock Options [Member]
Stockholders' Equity (Deficit) (Textual)
Number of stock issued						2,600,000
Consultant for business advisory services [Member] | Common Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock price per share		$ 0.09
Number of stock issued		2,600,000
Stock issued fair value		$ 234,000
Share Price		$ 0.09
Spin Off Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock issued in exchange	36,309,768
Spin Off Agreement [Member] | Common Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Shares cancelled of common stock	36,309,768

Commitments and Contingencies34

Commitments and Contingencies (Details)	Jun. 30, 2018USD ($)
Commitments and Contingencies [Abstract]
2,018	$ 20,000
2,019	50,000
2020 and every year thereafter on the same date, for the life of this License Agreement.	$ 100,000

Commitments and Contingencies35

Commitments and Contingencies (Details 1)	Jun. 30, 2018USD ($)
Commitments and Contingencies [Abstract]
2,018	$ 12,924
2,019	26,238
2,020	27,028
2,021	13,710
Total	$ 79,900

Commitments and Contingencies36

Commitments and Contingencies (Details Textual) - USD ($)	1 Months Ended		6 Months Ended
	Apr. 30, 2018	Mar. 31, 2018	Jun. 30, 2018
Commitments and Contingencies (Textual)
License agreement commitments, description			(i) three percent (3%) for Net Sales of Licensed Products, and Licensed Processes (all as defined in the License Agreement), for each product or process, on a country-by-country basis, for cumulative Net Sales up to one million dollars ($1,000,000); and (ii) four percent (4%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, for cumulative Net Sales from one million dollars ($1,000,000) to five million dollars ($5,000,000); and (iii) five percent (5%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, Net Sales over five million dollars ($5,000,000).
Royalty expense		$ 5,000
Monthly base rent	$ 2,154
Payment of license issue fees		$ 5,000
Lease agreement terms, description	The lease is for a period of 36 months commencing in July 2018 and expiring in July 2021. Pursuant to the lease agreement, the lease requires the Company to pay a monthly base rent of $2,154 plus a pro rata share of operating expenses beginning July 2018. The base rent is subject to annual increases beginning the 2nd and 3rd lease year as defined in the lease agreement.